فانجارد بلس 5 إل 4 لقاح الكلاب المركب المعزز بليبتوسبيرا الرباعية
Vanguard Plus 5 L4 is a modified live virus vaccine and Leptospira 4-way bacterin containing attenuated strains of canine distemper virus, adenovirus type 2, parainfluenza virus, canine parvovirus (including CPV-2c strain), and inactivated whole cultures of Leptospira canicola, L. grippotyphosa, L. icterohaemorrhagiae, and L. pomona. Demonstrated protection against respiratory disease, hepatitis, enteritis, and leptospirosis.
Dosage Form
Injection
Product Type
Biological
Manufacturer
Package
Cartons of 25 x 1-dose vials with 25 x 1-dose liquid Leptospira diluents
| Species | Dosage | Route | Duration |
|---|---|---|---|
| Dog | Reconstitute the freeze-dried vaccine with the accompanying liquid Leptospira bacterin and inject 1 mL subcutaneously or intramuscularly | Subcutaneous (SC) or Intramuscular (IM) | Initial vaccination at 6 weeks of age or older, repeated every 3 to 4 weeks until at least 12 weeks of age; revaccinate annually |
No withdrawal information available.
Immunization of healthy dogs 6 weeks of age or older against canine distemper virus, infectious canine hepatitis (canine adenovirus type 1), respiratory disease (canine adenovirus type 2), canine parainfluenza virus, canine parvovirus (CPV-2 and CPV-2c).
Prevention of leptospirosis and leptospiruria caused by Leptospira canicola, L. grippotyphosa, L. icterohaemorrhagiae, and L. pomona.
Do not vaccinate pregnant bitches.
Do not vaccinate clinically ill or immunosuppressed dogs.
Contains gentamicin as a preservative. Epinephrine should be available in case of rare post-vaccinal anaphylaxis.
Mild lethargy, temporary local soreness at the injection site, transient fever.
Vanguard Plus 5 L4 Prescribing Information
LeafletNo data available
Information has not been added yet.
Manufacturer
No alternatives available.